They can suppress both adaptive and innate aspects of the anti-tumor immune response in a TGFβ-dependent manner by inhibiting CD8 + T cells and NK cells, two of the immune system's primary anti-tumor weapons [47, 48]. Here, CD8A is linked to neoplasm.